India to Canada: Ertapenem Export Trade Route
India has recorded 47 verified shipments of Ertapenem exported to Canada, representing a combined trade value of $6.8M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $145.5K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 36% of total export value with 18 shipments worth $2.5M USD. On the buying side, EUGIA PHARMA INC, is the largest importer in Canada with $1.3M USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED , DR.REDDY'S LABORATORIES LTD — together control 80% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Canada Ertapenem corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $6.8M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's ertapenem manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $145.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 22.5%, placing it at rank #14 among India's top ertapenem export destinations globally.
On the import side, key buyers of Indian ertapenem in Canada include EUGIA PHARMA INC,, AURO PHARMA INC , AURO PHARMA INC, and 12 others. EUGIA PHARMA INC, is the single largest importer with 9 shipments valued at $1.3M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#14
- Annual growth+22.5%
- Demand growth+20.9%
- Regulatory ease67/100
Top 10 Indian Ertapenem Exporters to Canada
Showing top 10 of 6 Indian suppliers exporting Ertapenem to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED Avg $136.9K per shipment | 18 | $2.5M | 36.0% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED Avg $147.9K per shipment | 13 | $1.9M | 28.1% |
| 3 | DR.REDDY'S LABORATORIES LTD Avg $153.3K per shipment | 7 | $1.1M | 15.7% |
| 4 | DR.REDDY'S LABORATORIES LTD Avg $132.7K per shipment | 5 | $663.5K | 9.7% |
| 5 | DR REDDYS LABORATORIES LIMITED Avg $191.2K per shipment | 3 | $573.7K | 8.4% |
| 6 | DR REDDY S LABORATORIES LIMITED Avg $141.6K per shipment | 1 | $141.6K | 2.1% |
This table shows the top 10 of 6 Indian companies exporting ertapenem to Canada, ranked by total trade value. The listed exporters are: EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED , DR.REDDY'S LABORATORIES LTD , DR.REDDY'S LABORATORIES LTD, DR REDDYS LABORATORIES LIMITED, DR REDDY S LABORATORIES LIMITED. EUGIA PHARMA SPECIALITIES LIMITED is the dominant supplier with 18 shipments worth $2.5M USD, giving it a 36% market share. The top 3 suppliers together account for 80% of the total trade value on this route.
Top 10 Ertapenem Importers in Canada
Showing top 10 of 15 known buyers in Canada receiving Ertapenem shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ertapenem in Canada include EUGIA PHARMA INC,, AURO PHARMA INC , AURO PHARMA INC, , DR REDDYS LABORATORIES CANADA INC , AURO PHARMA INC, among 15 total buyers. The largest importer is EUGIA PHARMA INC,, accounting for $1.3M USD across 9 shipments — representing 19% of all ertapenem imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA INC, | 9 | $1.3M | 18.7% |
| 2 | AURO PHARMA INC | 8 | $1.2M | 17.5% |
| 3 | AURO PHARMA INC, | 5 | $727.4K | 10.6% |
| 4 | DR REDDYS LABORATORIES CANADA INC | 3 | $675.8K | 9.9% |
| 5 | AURO PHARMA INC | 5 | $622.2K | 9.1% |
| 6 | DR REDDYS LABORATORIES CANADA INC | 2 | $427.0K | 6.2% |
| 7 | DR REDDY S LABORATORIES CANADA INC | 3 | $425.5K | 6.2% |
| 8 | TO THE ORDER OF* . | 3 | $397.3K | 5.8% |
| 9 | EUGIA PHARMA INC | 2 | $284.7K | 4.2% |
| 10 | DR.REDDYS LABORATORIES CANADA INC | 2 | $260.2K | 3.8% |
Showing top 10 of 15 Ertapenem importers in Canada on this route.
Top 10 Ertapenem Formulations Imported by Canada
Showing top 10 of 37 product formulations shipped on the India to Canada Ertapenem route, ranked by trade value
Canada imports a wide range of ertapenem formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ERTAPENEM FOR INJECTION 1G/VIAL ( ERTAPE — accounts for $601.5K USD across 4 shipments. There are 37 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ERTAPENEM FOR INJECTION 1G/VIAL ( ERTAPE | 4 | $601.5K | 8.8% |
| 2 | ERTAPENEM FOR INJECTION 1G/VIAL(ERTAPENE | 4 | $593.7K | 8.7% |
| 3 | ERTAPENEM FOR INJ.1G/VIAL CA (2890 X 10 | 1 | $405.2K | 5.9% |
| 4 | ERTAPENEM FOR INJ IG/VIAL 10S CA | 3 | $397.3K | 5.8% |
| 5 | ERTAPENEM FOR INJ. 1G/VIAL 10S CA 1970X10S=19700NOS | 1 | $289.8K | 4.2% |
| 6 | ERTAPENEM FOR INJECTION 1 G VIAL ERTAPENEM FOR INJECTION 1G VIAL B N 2EI23005A MFG DT 01 2023 EXP DT 12 2024 | 2 | $276.8K | 4.0% |
| 7 | ERTAPENEM FOR INJ IG/VIAL 10S CA (963 X | 2 | $270.5K | 4.0% |
| 8 | ERTAPENEM FOR INJECTION 1 G/VIAL, (ERTAP | 1 | $153.7K | 2.2% |
| 9 | ERTAPENEM FOR INJECTION 1 G/VIAL(ERTAPE | 1 | $150.0K | 2.2% |
| 10 | ERTAPENEM FOR INJECTION 1G/VIAL (ERTAPENEM FOR INJECTION 1G/VIAL) B/N 2EI24109AM/D 06/2024 E/D 05/2026 | 1 | $148.8K | 2.2% |
Showing top 10 of 37 Ertapenem formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 9 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's ertapenem exports to Canada are driven primarily by a handful of large-scale manufacturers. EUGIA PHARMA SPECIALITIES LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED , DR.REDDY'S LABORATORIES LTD — together account for 80% of total trade value on this route. The average shipment value of $145.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as ertapenem for injection 1g/vial(ertapene and ertapenem for inj.1g/vial ca (2890 x 10 , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EUGIA PHARMA INC, is the largest importer with 9 shipments worth $1.3M USD — representing 19% of all ertapenem imports from India on this route. A total of 15 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.8M
- Avg. Shipment
- $145.5K
- Suppliers
- 6
- Buyers
- 15
- Transit (Sea)
- ~17 days
- Annual Growth
- +22.5%
Other Ertapenem Routes
Unlock the Full India to Canada Ertapenem Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 47 shipments on this route.
Frequently Asked Questions — India to Canada Ertapenem Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ertapenem to Canada?
The leading Indian exporters of Ertapenem to Canada are EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALITIES LIMITED , DR.REDDY'S LABORATORIES LTD . EUGIA PHARMA SPECIALITIES LIMITED holds the largest market share at approximately 36% of total trade value on this route.
Q What is the total value of Ertapenem exports from India to Canada?
India exports Ertapenem to Canada worth approximately $6.8M USD across 47 recorded shipments. The average value per shipment is $145.5K USD.
Q Which ports does India use to ship Ertapenem to Canada?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 9 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Canada for Ertapenem?
The average transit time for Ertapenem shipments from India to Canada is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Canada Ertapenem trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.5% with demand growth tracking at 20.9%. The route is ranked #14 among India's top Ertapenem export destinations globally.
Q How many suppliers are active on the India to Canada Ertapenem route?
There are currently 6 active Indian suppliers exporting Ertapenem to Canada. The market is moderately concentrated with EUGIA PHARMA SPECIALITIES LIMITED accounting for 36% of total shipment value.
Q Who are the main importers of Ertapenem from India in Canada?
The leading importers of Indian Ertapenem in Canada include EUGIA PHARMA INC,, AURO PHARMA INC , AURO PHARMA INC, , DR REDDYS LABORATORIES CANADA INC , AURO PHARMA INC. EUGIA PHARMA INC, is the largest buyer with 9 shipments worth $1.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Ertapenem.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 15 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 47 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
47 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists